Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDA) is characterized by an extremely poor prognosis. An inflammatory microenvironment triggers the pronounced desmoplasia, the selection of cancer stem-like cells (CSCs) and therapy resistance. The anti-inflammatory drug aspirin is suggested to lower the risk for P...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Zhang, Yiyao (VerfasserIn) , Liu, Li (VerfasserIn) , Fan, Pei (VerfasserIn) , Bauer, Nathalie (VerfasserIn) , Gladkich, Jury (VerfasserIn) , Ryschich, Eduard (VerfasserIn) , Bazhin, Alexandr V. (VerfasserIn) , Giese, Nathalia (VerfasserIn) , Strobel, Oliver (VerfasserIn) , Hackert, Thilo (VerfasserIn) , Hinz, Ulf (VerfasserIn) , Gross, Wolfgang (VerfasserIn) , Fortunato, Franco (VerfasserIn) , Herr, Ingrid (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: February 05, 2015
In: OncoTarget
Year: 2015, Jahrgang: 6, Heft: 12, Pages: 9999-10015
ISSN:1949-2553
DOI:10.18632/oncotarget.3171
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.18632/oncotarget.3171
Verlag, Volltext: http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=3171&path[]=8275
Volltext
Verfasserangaben:Yiyao Zhang, Li Liu, Pei Fan, Nathalie Bauer, Jury Gladkich, Eduard Ryschich, Alexandr V. Bazhin, Nathalia A. Giese, Oliver Strobel, Thilo Hackert, Ulf Hinz, Wolfgang Gross, Franco Fortunato, Ingrid Herr

MARC

LEADER 00000caa a2200000 c 4500
001 1585934534
003 DE-627
005 20230427034154.0
007 cr uuu---uuuuu
008 190104s2015 xx |||||o 00| ||eng c
024 7 |a 10.18632/oncotarget.3171  |2 doi 
035 |a (DE-627)1585934534 
035 |a (DE-576)515934534 
035 |a (DE-599)BSZ515934534 
035 |a (OCoLC)1341031106 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Zhang, Yiyao  |d 1980-  |e VerfasserIn  |0 (DE-588)1056054182  |0 (DE-627)793889812  |0 (DE-576)412062550  |4 aut 
245 1 0 |a Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer  |c Yiyao Zhang, Li Liu, Pei Fan, Nathalie Bauer, Jury Gladkich, Eduard Ryschich, Alexandr V. Bazhin, Nathalia A. Giese, Oliver Strobel, Thilo Hackert, Ulf Hinz, Wolfgang Gross, Franco Fortunato, Ingrid Herr 
264 1 |c February 05, 2015 
300 |a 17 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.01.2019 
520 |a Pancreatic ductal adenocarcinoma (PDA) is characterized by an extremely poor prognosis. An inflammatory microenvironment triggers the pronounced desmoplasia, the selection of cancer stem-like cells (CSCs) and therapy resistance. The anti-inflammatory drug aspirin is suggested to lower the risk for PDA and to improve the treatment, although available results are conflicting and the effect of aspirin to CSC characteristics and desmoplasia in PDA has not yet been investigated. We characterized the influence of aspirin on CSC features, stromal reactions and gemcitabine resistance. Four established and 3 primary PDA cell lines, non-malignant cells, 3 patient tumor-derived CSC-enriched spheroidal cultures and tissues from patients who did or did not receive aspirin before surgery were analyzed using MTT assays, flow cytometry, colony and spheroid formation assays, Western blot analysis, antibody protein arrays, electrophoretic mobility shift assays (EMSAs), immunohistochemistry and in vivo xenotransplantation. Aspirin significantly induced apoptosis and reduced the viability, self-renewal potential, and expression of proteins involved in inflammation and stem cell signaling. Aspirin also reduced the growth and invasion of tumors in vivo, and it significantly prolonged the survival of mice with orthotopic pancreatic xenografts in combination with gemcitabine. This was associated with a decreased expression of markers for progression, inflammation and desmoplasia. These findings were confirmed in tissue samples obtained from patients who had or had not taken aspirin before surgery. Importantly, aspirin sensitized cells that were resistant to gemcitabine and thereby enhanced the therapeutic efficacy. Aspirin showed no obvious toxic effects on normal cells, chick embryos or mice. These results highlight aspirin as an effective, inexpensive and well-tolerated co-treatment to target inflammation, desmoplasia and CSC features PDA. 
700 1 |a Liu, Li  |d 1979-  |e VerfasserIn  |0 (DE-588)1025450906  |0 (DE-627)722293267  |0 (DE-576)370359291  |4 aut 
700 1 |a Fan, Pei  |d 1983-  |e VerfasserIn  |0 (DE-588)1079392424  |0 (DE-627)840955251  |0 (DE-576)452438365  |4 aut 
700 1 |a Bauer, Nathalie  |d 1989-  |e VerfasserIn  |0 (DE-588)1079104771  |0 (DE-627)840210582  |0 (DE-576)452198089  |4 aut 
700 1 |a Gladkich, Jury  |e VerfasserIn  |0 (DE-588)1078800960  |0 (DE-627)839492529  |0 (DE-576)45190480X  |4 aut 
700 1 |a Ryschich, Eduard  |d 1967-  |e VerfasserIn  |0 (DE-588)120246546  |0 (DE-627)696498340  |0 (DE-576)292118090  |4 aut 
700 1 |a Bazhin, Alexandr V.  |e VerfasserIn  |0 (DE-588)1025289552  |0 (DE-627)721987710  |0 (DE-576)370168046  |4 aut 
700 1 |a Giese, Nathalia  |e VerfasserIn  |0 (DE-588)1033180955  |0 (DE-627)740120018  |0 (DE-576)380769123  |4 aut 
700 1 |a Strobel, Oliver  |d 1974-  |e VerfasserIn  |0 (DE-588)123658977  |0 (DE-627)706385101  |0 (DE-576)293812357  |4 aut 
700 1 |a Hackert, Thilo  |d 1971-  |e VerfasserIn  |0 (DE-588)122158512  |0 (DE-627)70579346X  |0 (DE-576)182659208  |4 aut 
700 1 |a Hinz, Ulf  |e VerfasserIn  |0 (DE-588)1022150499  |0 (DE-627)716927748  |0 (DE-576)175505284  |4 aut 
700 1 |a Gross, Wolfgang  |d 1954-  |e VerfasserIn  |0 (DE-588)1074045599  |0 (DE-627)83021576X  |0 (DE-576)435557963  |4 aut 
700 1 |a Fortunato, Franco  |e VerfasserIn  |0 (DE-588)1071580019  |0 (DE-627)826057845  |0 (DE-576)433166436  |4 aut 
700 1 |a Herr, Ingrid  |e VerfasserIn  |0 (DE-588)114884242  |0 (DE-627)691233276  |0 (DE-576)168702436  |4 aut 
773 0 8 |i Enthalten in  |t OncoTarget  |d [Erscheinungsort nicht ermittelbar] : Impact Journals LLC, 2010  |g 6(2015), 12, Seite 9999-10015  |h Online-Ressource  |w (DE-627)63035975X  |w (DE-600)2560162-3  |w (DE-576)325343764  |x 1949-2553  |7 nnas  |a Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer 
773 1 8 |g volume:6  |g year:2015  |g number:12  |g pages:9999-10015  |g extent:17  |a Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer 
856 4 0 |u http://dx.doi.org/10.18632/oncotarget.3171  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=3171&path[]=8275  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190104 
993 |a Article 
994 |a 2015 
998 |g 114884242  |a Herr, Ingrid  |m 114884242:Herr, Ingrid  |d 910000  |d 910200  |e 910000PH114884242  |e 910200PH114884242  |k 0/910000/  |k 1/910000/910200/  |p 14  |y j 
998 |g 1071580019  |a Fortunato, Franco  |m 1071580019:Fortunato, Franco  |d 910000  |d 910200  |e 910000PF1071580019  |e 910200PF1071580019  |k 0/910000/  |k 1/910000/910200/  |p 13 
998 |g 1074045599  |a Gross, Wolfgang  |m 1074045599:Gross, Wolfgang  |d 910000  |d 910200  |e 910000PG1074045599  |e 910200PG1074045599  |k 0/910000/  |k 1/910000/910200/  |p 12 
998 |g 1022150499  |a Hinz, Ulf  |m 1022150499:Hinz, Ulf  |d 910000  |d 910200  |e 910000PH1022150499  |e 910200PH1022150499  |k 0/910000/  |k 1/910000/910200/  |p 11 
998 |g 122158512  |a Hackert, Thilo  |m 122158512:Hackert, Thilo  |d 910000  |d 910200  |e 910000PH122158512  |e 910200PH122158512  |k 0/910000/  |k 1/910000/910200/  |p 10 
998 |g 123658977  |a Strobel, Oliver  |m 123658977:Strobel, Oliver  |d 910000  |d 910200  |e 910000PS123658977  |e 910200PS123658977  |k 0/910000/  |k 1/910000/910200/  |p 9 
998 |g 1033180955  |a Giese, Nathalia  |m 1033180955:Giese, Nathalia  |d 910000  |d 910200  |e 910000PG1033180955  |e 910200PG1033180955  |k 0/910000/  |k 1/910000/910200/  |p 8 
998 |g 1025289552  |a Bazhin, Alexandr V.  |m 1025289552:Bazhin, Alexandr V.  |d 60000  |d 50000  |e 60000PB1025289552  |e 50000PB1025289552  |k 0/60000/  |k 0/50000/  |p 7 
998 |g 120246546  |a Ryschich, Eduard  |m 120246546:Ryschich, Eduard  |d 910000  |d 910200  |e 910000PR120246546  |e 910200PR120246546  |k 0/910000/  |k 1/910000/910200/  |p 6 
998 |g 1078800960  |a Gladkich, Jury  |m 1078800960:Gladkich, Jury  |p 5 
998 |g 1079104771  |a Bauer, Nathalie  |m 1079104771:Bauer, Nathalie  |d 910000  |d 910200  |e 910000PB1079104771  |e 910200PB1079104771  |k 0/910000/  |k 1/910000/910200/  |p 4 
998 |g 1079392424  |a Fan, Pei  |m 1079392424:Fan, Pei  |d 910000  |d 910200  |e 910000PF1079392424  |e 910200PF1079392424  |k 0/910000/  |k 1/910000/910200/  |p 3 
998 |g 1025450906  |a Liu, Li  |m 1025450906:Liu, Li  |d 50000  |e 50000PL1025450906  |k 0/50000/  |p 2 
998 |g 1056054182  |a Zhang, Yiyao  |m 1056054182:Zhang, Yiyao  |p 1  |x j 
999 |a KXP-PPN1585934534  |e 3039100491 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer","title":"Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer"}],"name":{"displayForm":["Yiyao Zhang, Li Liu, Pei Fan, Nathalie Bauer, Jury Gladkich, Eduard Ryschich, Alexandr V. Bazhin, Nathalia A. Giese, Oliver Strobel, Thilo Hackert, Ulf Hinz, Wolfgang Gross, Franco Fortunato, Ingrid Herr"]},"language":["eng"],"note":["Gesehen am 04.01.2019"],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"2010-","publisher":"Impact Journals LLC","dateIssuedKey":"2010","publisherPlace":"[Erscheinungsort nicht ermittelbar]"}],"pubHistory":["1.2010,Mai -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"issue":"12","year":"2015","text":"6(2015), 12, Seite 9999-10015","pages":"9999-10015","volume":"6","extent":"17"},"disp":"Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancerOncoTarget","title":[{"title":"OncoTarget","subtitle":"open access impact journal","title_sort":"OncoTarget"}],"language":["eng"],"note":["Gesehen am 16.08.2018"],"recId":"63035975X","id":{"zdb":["2560162-3"],"eki":["63035975X"],"issn":["1949-2553"]}}],"recId":"1585934534","person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Zhang, Yiyao","family":"Zhang","given":"Yiyao"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Liu, Li","family":"Liu","given":"Li"},{"given":"Pei","display":"Fan, Pei","family":"Fan","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","role":"aut","display":"Bauer, Nathalie","family":"Bauer","given":"Nathalie"},{"display":"Gladkich, Jury","family":"Gladkich","roleDisplay":"VerfasserIn","role":"aut","given":"Jury"},{"display":"Ryschich, Eduard","family":"Ryschich","roleDisplay":"VerfasserIn","role":"aut","given":"Eduard"},{"roleDisplay":"VerfasserIn","role":"aut","display":"Bazhin, Alexandr V.","family":"Bazhin","given":"Alexandr V."},{"given":"Nathalia","family":"Giese","display":"Giese, Nathalia","role":"aut","roleDisplay":"VerfasserIn"},{"given":"Oliver","role":"aut","roleDisplay":"VerfasserIn","display":"Strobel, Oliver","family":"Strobel"},{"roleDisplay":"VerfasserIn","role":"aut","family":"Hackert","display":"Hackert, Thilo","given":"Thilo"},{"family":"Hinz","display":"Hinz, Ulf","roleDisplay":"VerfasserIn","role":"aut","given":"Ulf"},{"family":"Gross","display":"Gross, Wolfgang","role":"aut","roleDisplay":"VerfasserIn","given":"Wolfgang"},{"given":"Franco","family":"Fortunato","display":"Fortunato, Franco","role":"aut","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Herr, Ingrid","family":"Herr","given":"Ingrid"}],"id":{"doi":["10.18632/oncotarget.3171"],"eki":["1585934534"]},"physDesc":[{"extent":"17 S."}],"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"February 05, 2015"}],"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a ZHANGYIYAOASPIRINCOU0520